| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.1M | -22.2% |
| SG&A Expense | $22.8M | +13.0% |
| Operating Income | -$49.3M | +3.8% |
| Interest Expense | $11.4M | -1.4% |
| Pre-tax Income | -$59.1M | +5.2% |
| Income Tax | $0 | -100.0% |
| Net Income | -$59.1M | +5.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.3M | +328.0% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $21.6M | -43.9% |
| Total Assets | $26.1M | -40.6% |
| Current Liabilities | $5.0M | -62.9% |
| Total Liabilities | $157.3M | +2.7% |
| Stockholders' Equity | -$131.2M | -20.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.8M | -3.3% |
| Capital Expenditures | $59K | +136.0% |
| Investing Cash Flow | $27.3M | +13.7% |
| Financing Cash Flow | $31.5M | +709.9% |
| Free Cash Flow | -$44.9M | -3.4% |